NFE2L2 and diabetic kidney disease: In addition to demonstrating the therapeutic potential of digitoflavone in suppressing the pathogenesis of diabetic nephropathy, we also sought to determine the mechanism by which digitoflavone-induced Nrf2 activation produces beneficial effects.